Midatech Pharma Plc Sponsored ADR Stock
Midatech Pharma Plc Sponsored ADR Stock price
Key metrics
| Market capitalization | $1.01m |
| Enterprise Value | $-170.00k |
| P/E (TTM) P/E ratio | negative |
| EV/FCF (TTM) EV/FCF | 0.01 |
| P/B ratio (TTM) P/B ratio | 3.40 |
| Revenue growth (TTM) Revenue growth | -100.00% |
| Revenue (TTM) Revenue | $0.00 |
| EBIT (operating result TTM) EBIT | $-11.80m |
| Free Cash Flow (TTM) Free Cash Flow | $-15.61m |
Is Midatech Pharma Plc Sponsored ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.
Midatech Pharma Plc Sponsored ADR Stock Analysis
Analyst Opinions
1 Analyst has issued a forecast Midatech Pharma Plc Sponsored ADR:
Analyst Opinions
1 Analyst has issued a forecast Midatech Pharma Plc Sponsored ADR:
Financial data from Midatech Pharma Plc Sponsored ADR
| Dec '24 |
+/-
%
|
||
| Revenue | - - |
-
|
|
| Gross Profit | -0.32 -0.32 |
-
|
|
| EBITDA | -11 -11 |
19%
19%
|
EBIT (Operating Income) EBIT | -12 -12 |
18%
18%
|
| Net Profit | -7.31 -7.31 |
17%
17%
|
|
In millions USD.
Don't miss a Thing! We will send you all news about Midatech Pharma Plc Sponsored ADR directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Midatech Pharma Plc Sponsored ADR Stock News
Company Profile
Midatech Pharma Plc commercializes oncology treatments and cancer supportive care products through its U.S. commercial organization, Midatech Pharma US. The company engages in the development of pharmaceutical products utilizing its nanomedicine and sustained release technologies. Its pipeline includes MTD119, MTX102, MTD201 and MTX110. Midatech Pharma was founded on September 12, 2014 and is headquartered in Cardiff, the United Kingdom.
| Head office | United Kingdom |
| CEO | Stephen Stamp |
| Employees | 13 |
| Founded | 2000 |
| Website | www.biodexapharma.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
